Endovascular anastomotic connector device, delivery system, and methods of delivery and use

Information

  • Patent Grant
  • 11241231
  • Patent Number
    11,241,231
  • Date Filed
    Friday, November 2, 2018
    5 years ago
  • Date Issued
    Tuesday, February 8, 2022
    2 years ago
Abstract
An endovascular anastomotic connector and method of using the same. The endovascular anastomotic connector includes a vascular conduit and a supply conduit. The vascular conduit has proximal and distal ends that reside within a vascular structure. The supply conduit extends at an angle from the vascular conduit. The proximal end of the supply conduit is configured to be attached to an auxiliary device.
Description
TECHNICAL FIELD

The present invention relates generally to vascular connector devices and methods of using the same. More specifically, the invention relates to an endovascular anastomotic connector, a delivery system, and a method of delivery.


BACKGROUND

The circulatory system of the human body transports blood containing chemicals, such as metabolites and hormones, and cellular waste products to and from the cells. This organ system includes the heart, blood, and a vascular network. Veins are vessels that carry blood toward the heart while arteries carry blood away from the heart. The human heart consists of two atrial chambers and two ventricular chambers. Atrial chambers receive blood from the veins and the ventricular chambers, which include larger muscular walls, pump blood from the heart. Movement of the blood is as follows: blood enters the right atrium from either the superior or the inferior vena cava and moves into the right ventricle. From the right ventricle, blood is pumped to the lungs via pulmonary arteries to become oxygenated. Once the blood has been oxygenated, the blood returns to the heart by entering the left atrium, via the pulmonary veins, and flows into the left ventricle. Finally, the blood is pumped from the left ventricle into the aorta and the vascular network.


In some instances, it becomes necessary to maintain fluidic communication with the vascular network. For example, a circulatory assist system uses a pump to aid in moving blood through the vascular network, thereby relieving the symptoms associated with congestive heart failure (commonly referred to as heart disease). The pump of the circulatory assist system includes inflow and outflow cannulae. Often the inflow cannula connects the left atrium of the heart to the pump; the outflow cannula connects the pump to a peripheral artery. The outflow cannula must be stabilized within the peripheral artery to ensure proper functioning of the circulatory assist system and reduce the risk of bleeding. Accordingly, it would be beneficial to have devices that can be delivered and secured to a peripheral vessel but are also capable of being attached to an auxiliary device.


SUMMARY

In one illustrative embodiment of the present invention, an anastomotic connector is described. The anastomotic connector includes a vascular conduit and a supply conduit. The vascular conduit has proximal and distal ends that reside within a vascular structure. The supply conduit extends at an angle from the vascular conduit. The proximal end of the supply conduit is configured to extend from the vascular structure and attach to an auxiliary device.


In another illustrative embodiment of the present invention, a delivery system is described and includes the anastomotic connector and a delivery subassembly. The delivery subassembly includes a multi-lumen hub, a multi-lumen delivery shaft, and a secondary delivery shaft. The multi-lumen delivery shaft extends from the multi-lumen hub, through the lumen of the supply conduit, and out from the distal end of the vascular conduit. The secondary delivery shaft extends from the multi-lumen hub, into the proximal end of the vascular conduit, and out from the distal end of the vascular conduit. A proximal portion of the secondary delivery shaft extending from the distal end of the vascular conduit is received by a first lumen of the multi-lumen delivery shaft.





BRIEF DESCRIPTION OF THE FIGURES


FIG. 1 is a diagrammatic view of a circulatory assist system with the outflow of the pump being connected to a peripheral artery with an endovascular anastomotic connector, shown in partial cross-section.



FIG. 1A is a side-elevational view, in partial cross section, of the endovascular anastomotic connector in a peripheral artery.



FIG. 2 is a side-elevational view, in partial cross section, of a delivery subassembly for advancing and deploying the endovascular anastomotic connector.



FIG. 3 is a side-elevational view, in partial cross section, of a multi-lumen delivery shaft of the delivery subassembly.



FIG. 4A is a cross-sectional view of the multi-lumen delivery shaft taken along the line 4A-4A of FIG. 3.



FIG. 4B is an isometric view of the multi-lumen delivery shaft with the secondary delivery shaft taken from the enclosure 4B of FIG. 2.



FIG. 5 is a partial side-elevational view, in partial cross section, of the multi-lumen hub and a luer adapter of the delivery subassembly.



FIG. 6 is a side-elevational view of the secondary delivery shaft of the delivery subassembly.



FIG. 7A is a side-elevational view of one exemplary method of loading the endovascular anastomotic connector onto the delivery subassembly.



FIG. 7B is a side-elevational view, in partial cross section, of the delivery assembly.



FIG. 7C is a cross-sectional view of one exemplary method of folding the endovascular anastomotic connector around the delivery subassembly, taken along the line 7C-7C of FIG. 7B.



FIGS. 8 and 9 are side-elevational views illustrating successive steps of one exemplary procedure for loading the delivery assembly into a delivery sheath.



FIGS. 10-16 are side-elevational views, in partial cross section, illustrating successive steps of one exemplary procedure for inserting and deploying the endovascular anastomotic connector in a peripheral artery.



FIG. 17 is a side-elevational view, in partial cross section, of the deployed endovascular anastomotic connector in the peripheral artery.





DETAILED DESCRIPTION


FIG. 1 illustrates an implanted circulatory assist system 10. For illustrative purposes, certain anatomy is shown including the heart 12 of a patient 14 having a right atrium 16, a left atrium 18, a right ventricle 20, and a left ventricle 22. Blood from the left and right subclavian veins 24, 26 and the left and right jugular veins 28, 30 enters the right atrium 16 through the superior vena cava 32 while blood from the lower parts of the body enters the right atrium 16 through the inferior vena cava 34. The blood is pumped from the right atrium 16, to the right ventricle 20, and to the lungs (not shown) to be oxygenated. Blood returning from the lungs enters the left atrium 18 via pulmonary veins 35 and is then pumped into the left ventricle 22. Blood leaving the left ventricle 22 enters the aortic arch 36 and flows into the left subclavian artery 38, the left common carotid 40, and the brachiocephalic trunk 42 including the right subclavian artery 44 and the right common carotid 46.


With respect to the implanted circulatory assist system 10, a flexible cannula body 48 extends from within the left atrium 18, through the intra-atrial septum 50, and percutaneously to a vascular access site 52 in the right subclavian vein 26. The flexible cannula body 48 is attached to an input port 54 of an implantable pump 56. An endovascular anastomotic connector 58 connects an output port 60 of the implantable pump 56 to a suitable superficial artery, such as the right subclavian artery 44. The physician can position the implantable pump 56 subcutaneously and, optionally, submuscularly in a pump pocket 57 located near the vascular access site 52 or maintain the pump 56 externally.


The endovascular anastomotic connector 58 is shown in greater detail in FIG. 1A. For illustrative purposes, the endovascular anastomotic connector 58 is shown to be implanted within the right subclavian artery 44; however, any suitable peripheral vessel could be used. The endovascular anastomotic connector 58 includes a vascular conduit 62 and a supply conduit 64 that extends angularly from the vascular conduit 62. The junction between the vascular and supply conduits 62, 64 forms a bifurcation joint 66. In some embodiments, the vascular conduit 62 can be a vascular stent.


The vascular and supply conduits 62, 64 can each include support structures 67, 68, 69 constructed from continuous wire or laser cut from a hypotube or rolled sheet stock. The support structures 67, 68, 69 are then encapsulated within an expandable material. The expandable material can be superelastic and self-expanding, such as nickel titanium (NiTi). Alternatively, a balloon-expandable material, such as nickel cobalt (NiCo) or chromium cobalt (CrCo) can be used. The expandable material can then be coated with a porous material to allow for the migration of endothelial cells, and to secure the conduits 62, 64 to the wall of the vessel. Suitable porous materials can include expanded polytetrafluoroethylene (ePTFE), woven polyester, velour, or DACRON brand of synthetic polyester fabric. In some embodiments, the wall thickness of the vascular conduit 62 can be thinner than the wall thickness of the supply conduit 64 to allow the vascular conduit 62 to conform to the lumen of the blood vessel while not obstructing the flow of blood through the vessel. This is more preferred over the reverse because the vascular conduit 62 is implanted within the vessel and the profile should be minimized so as to not interfere with blood flow.


The bifurcated joint 66 should be flexible and replicate the vessel's native compliance. The bifurcated joint 66 can form an angle, θ, which can vary from about 5° to about 90° (i.e., perpendicular) depending on the intended use of the endovascular anastomotic connector 58 and the local anatomy.


Turning now to FIG. 2, a delivery subassembly 74 for delivering the endovascular anastomotic connector 58 (FIG. 1A) is shown. The delivery subassembly 74 includes a multi-lumen delivery shaft 76 and a secondary delivery shaft 78.


The multi-lumen delivery shaft 76, illustrated alone in FIG. 3, includes a multi-lumen tube 80 having a formed tip 82 and a multi-lumen hub 84. The cross-section of one suitable multi-lumen tube 80 is shown in FIG. 4A and includes primary and secondary lumens 86, 88, both of which extend from the distal formed tip 82 to the multi-lumen hub 84. The primary lumen 86 is sized to receive a conventional guide-wire. The secondary lumen 88 is sized to receive the secondary delivery shaft 78 and can be slotted to aid in assembly as will be described below. The multi-lumen tube 80 can be constructed by an extrusion process from a thermoplastic material. The formed tip 82 minimizes trauma to vascular tissues as the delivery subassembly 74 is advanced through the vascular network.



FIG. 4B is an enlarged view of one manner by which the secondary lumen 88 of the multi-lumen delivery shaft 76 receives a portion of the secondary delivery shaft 78, as illustrated in FIG. 2.



FIG. 5 illustrates, in greater detail, the multi-lumen hub 84. The multi-lumen hub 84 can be molded directly onto the proximal end of the multi-lumen tube 80 or molded separately and then affixed to the multi-lumen tube 80 with an epoxy or a biocompatible adhesive, such as UV or cyanoacrylate. A luer adaptor 90 is connected to a first lumen 92 for flushing the primary lumen 86 (FIG. 4) of the multi-lumen tube 80 prior to implantation. A second lumen 94 of the multi-lumen hub 84 is sized to receive the secondary delivery shaft 78.



FIG. 6 illustrates the secondary delivery shaft 78, which can include a single lumen tube 96 and a proximal hub luer 98. The single lumen tube 96 can be constructed using an extrusion process and can be sized to receive a conventional guide-wire. The hub luer 98 can be separately constructed and attached to the single lumen tube 96 with a biocompatible adhesive or epoxy. The hub luer 98 allows flushing of the secondary delivery shaft 78 prior to insertion.



FIGS. 7A-7C illustrate one method of loading the endovascular anastomotic connector 58 onto the delivery subassembly 74. It should be noted that the delivery subassembly 74 has been rotated 180° about a longitudinal, lengthwise axis for illustrating the loading and delivery of the endovascular anastomotic connector 58.


In FIG. 7A the multi-lumen delivery shaft 76 is directed into the proximal end of the supply conduit 64. The formed tip 82 is advanced through the supply conduit 64 until it exits from the distal end 72 of the vascular conduit 62. The secondary delivery shaft 78 is advanced through the second lumen 94 of the multi-lumen hub 84, along the outside of the supply conduit 64, and into the proximal end 70 of the vascular conduit 62. The distal end of the secondary delivery shaft 78 is then advanced beyond the distal end 72 of the vascular conduit 62 and clipped into the slotted secondary lumen 88 of the multi-lumen tube 80. The assembled delivery system 100 is shown in FIG. 7B.


The endovascular anastomotic connector 58 can be folded about the delivery subassembly 74 to minimize the delivery system profile. One manner of folding the endovascular anastomotic connector 58 includes collapsing the support structures 67, 69 (FIG. 1A) of the distal end 72 of the vascular conduit 62 and the supply conduit 67, respectively and wrapping the distal end 72 and the supply conduit 67 around the multi-lumen delivery shaft 76. Then, after the secondary delivery shaft 78 is inserted through the proximal end 70 of the vascular conduit 62, the support structure 68 is collapsed and the proximal end 70 is wrapped around the supply conduit 64 in a “c” shape, as shown in FIG. 7C. In this way, the vascular conduit 62 can be deployed and positioned within the vessel before the supply conduit 64 seals the incision in the wall of the vessel.


After assembly, the delivery system 100 is back-loaded into a delivery sheath 102, as shown in FIG. 8. The delivery sheath 102 can be constructed from a peel-away sheath design for ease of removal. FIG. 9 illustrates the delivery system 100 loaded within the delivery sheath 102.


One manner of inserting the endovascular anastomotic connector 58 into a vessel can now be described with reference to FIGS. 10-16. The method begins with the physician creating an incision 103 into a suitable peripheral vessel, illustrated here as the right subclavian artery 44. The selection of the peripheral vessel is dependent on the particular surgical procedure. For example, in the implantation of the circulatory assist system 10 (FIG. 1), the right subclavian artery 44 can be appropriate when the pump pocket 57 (FIG. 1) is located near the right subclavian vein 26. An introducer 104 can be directed into the right subclavian artery 44 to maintain the incision 103 into the vessel. A suitable introducer 104 could include those that are commercially available or a custom introducer, such as the one disclosed in U.S. Provisional Patent Application No. 61/163,931, filed on Mar. 27, 2009, the disclosure of which is incorporated herein by reference. The illustrated introducer 104 includes a sheath 106 with a proximal hub 108. The hub includes a side port 110 and a valve 112 for fluidic access.


The physician can then create a secondary incision site (not shown) that is remotely located from the incision 103 in the right subclavian artery 44. For the incision 103 in the right subclavian artery 44, a suitable secondary incision site could be, for example, near the right femoral vein (not shown). A first guide-wire 114 is then directed percutaneously from the secondary incision site to the right subclavian artery 44 and through the introducer 104. The first guide-wire 114 is then directed into the distal end of the secondary delivery shaft 78. In some embodiments, the physician can direct the first guide-wire 114 through the entire length of the secondary delivery shaft 78, alternatively the first guide-wire 114 is advanced about 10 mm to about 20 mm into the secondary delivery shaft 78.


As shown in FIG. 11, a second guide-wire 116 is advanced through the primary lumen 86 (FIG. 4) of the multi-lumen tube 80 until it extends distally from the formed tip 82. The second guide-wire 116 is then advanced into the right subclavian artery 44 via the introducer 104.


With the guide-wires 114, 116 in position, the delivery system 100 with the delivery sheath 102 can be advanced, as a unit, into the introducer 104, as shown in FIG. 12, while the positions of the guide-wires 114, 116 and the introducer 104 are maintained. The delivery system 100 is advanced until the formed tip 82 is positioned as shown in FIG. 13, i.e., the formed tip 82 should be positioned distal to the delivery sheath 102 and within the right subclavian artery 44. In some embodiments, the formed tip 82 can include one or more radiopaque markers for in vivo visualization under a suitable viewing device during the positioning procedure. The physician then additionally, or alternatively, visualizes the positioning of the support structures 67, 68, 69 within the artery 44 (refer again to FIG. 1A). One such proper position can place the vascular conduit 62 just distal to the incision 103.



FIG. 14 illustrates the removal of the delivery sheath 102 to deploy the endovascular anastomotic connector 58. In embodiments where the delivery sheath 102 is constructed from a peel-away sheath design, the delivery sheath 102 is removed by pulling the ends 118, 120 of the delivery sheath 102 apart.


Once the delivery sheath 102 is sufficiently removed, the endovascular anastomotic connector 58 automatically deploys within the right subclavian artery 44. The proximal end 70 of the vascular conduit 62 is unfolded from around the supply conduit 64 and radially expanded against the inner wall of the right subclavian artery 44 by the support structure 67 (FIG. 1A). The supply conduit 64 can remain constrained by the sheath 106 of the introducer 104 during this manipulation.


As illustrated in FIG. 15, the first guide-wire 114 is retracted from its position within the secondary delivery shaft 78 and is advanced through the vascular conduit 62 and beyond the proximal end 70. The secondary delivery shaft 78 can then be removed.


The physician can then pull proximally on the multi-lumen delivery shaft 76 and the supply conduit 64 to reposition the vascular conduit 62 and bridge the incision 103 in the wall of the right subclavian artery 44. Repositioning is structurally supported by the multi-lumen delivery shaft 76. The introducer 104 and the multi-lumen delivery shaft 76 can then be retracted from the right subclavian artery 44 leaving the endovascular anastomotic connector 58, as shown in FIG. 16.



FIG. 16 further illustrates the proximal and distal ends 70, 72 of the vascular conduit 62 each including a flare (shown in phantom), which allows the vascular conduit 62 to accommodate a wider range of vessel sizes and to provide for a smooth transition between the vascular conduit 62 and the vessel.


Once the sheath 106 of the introducer 104 is removed, the support structure 69 (FIG. 1A) of the supply conduit 64 will cause the supply conduit 64 to automatically expand radially, as shown in FIG. 17.


Though not shown, the physician can ensure full radial expansion of the support structures 67, 68, 69 (FIG. 1A) by advancing a balloon dilation catheter to the endovascular anastomotic connector 58. The balloon dilation catheter can be advanced over the first or second guide-wires 114, 116 depending on which portion of the endovascular anastomotic connector 58 is being expanded. That is, to fully expand the vascular conduit 62, the balloon dilation catheter is advanced over the first guide-wire 114 and is positioned within the vascular conduit 62 at one of the support structures 67, 68 (FIG. 1A). The balloon dilation catheter is inflated and then deflated. The physician can then either remove or reposition the balloon dilation catheter at another support structure 68, 67 (FIG. 1A) within the vascular conduit 62.


To fully expand the bifurcation joint 66, the physician directs a balloon dilation catheter over the second guide-wire 116. Inflation of the balloon dilation catheter causes the bifurcation joint 66 to expand and seal the incision 103 in the wall of the right subclavian artery 44. In some embodiments, the physician can inflate and deflate the balloon dilation catheter multiple times, in the same or different positions, within the bifurcation joint 66 to ensure a complete expansion.


The balloon dilation catheter and guide-wires 114, 116 are then removed. The physician can then cap or clamp (not shown) the proximal end of the supply conduit 64 to prevent bleeding through its lumen. When attaching the auxiliary device to the supply conduit 64, the physician can deair the supply conduit 64 by back bleeding or inserting a needle through the cap to draw out the air.


While the present invention has been illustrated by a description of various preferred embodiments and while these embodiments have been described in some detail, it is not the intention of the Applicants to restrict or in any way limit the scope of the appended claims to such detail. Additional advantages and modifications will readily appear to those skilled in the art. The various features of the invention may be used alone or in any combination depending on the needs and preferences of the user. This has been a description of the present invention, along with the preferred methods of practicing the present invention as currently known. However, the invention itself should only be defined by the appended claims.

Claims
  • 1. A method of connecting a peripheral vessel to an auxiliary device with an anastomotic connector comprising a vascular conduit and a supply conduit, the vascular conduit having proximal and distal ends and is configured to reside within the peripheral vessel, the supply conduit having proximal and distal ends, wherein the distal end of the supply conduit forms a bifurcation joint with the vascular conduit and the proximal end of the supply conduit is configured to couple to the auxiliary device, the method comprising: loading the anastomotic connector onto a delivery subassembly including a multi-lumen hub, the delivery subassembly including a multi-lumen delivery shaft configured to extend from the multi-lumen hub, through a lumen of the supply conduit, through a lumen of the distal end of the vascular conduit, and distally from the distal end of the vascular conduit;directing the delivery subassembly with the anastomotic connector into the peripheral vessel;deploying the vascular conduit within the peripheral vessel;deploying the supply conduit;retracting the delivery subassembly; andconnecting the auxiliary device to the proximal end of the supply conduit.
  • 2. The method according to claim 1, wherein loading the anastomotic connector includes wrapping the proximal end of the vascular conduit around the supply conduit.
  • 3. The method according to claim 1, wherein the delivery subassembly comprises: a secondary delivery shaft configured to extend from the multi-lumen hub, into the proximal end of the vascular conduit, through a lumen of the vascular conduit, and distally from the distal end of the vascular conduit, wherein a distal portion of the secondary delivery shaft is received by a first lumen of the multi-lumen delivery shaft.
  • 4. The method according to claim 3 further comprising: creating an incision into the peripheral vessel and maintaining the incision with an introducer before directing the delivery subassembly with the anastomotic connector into the peripheral vessel.
  • 5. The method according to claim 4 further comprising: directing a first guide-wire through a second lumen of the multi-lumen delivery shaft, into the introducer, and into the peripheral vessel; andadvancing the delivery subassembly with the anastomotic connector over the first guide-wire and into the peripheral vessel.
  • 6. The method according to claim 5 further comprising: creating a secondary incision site that is remotely located from the incision in the peripheral vessel;directing a second guide-wire percutaneously from the secondary incision site to the anastomotic connector within the peripheral vessel; anddirecting the second guide-wire through the vascular conduit after the vascular conduit is deployed.
  • 7. The method according to claim 1, wherein the delivery subassembly is received by a delivery sheath and moves relative thereto.
  • 8. The method according to claim 7, wherein the deploying steps include retracting the delivery sheath.
  • 9. The method according to claim 1, wherein the vascular and supply conduits include support structures constructed from a continuous wire, a hypotube, or a rolled sheet stock.
  • 10. The method according to claim 9 further comprising: directing a balloon dilation catheter through the supply conduit to the vascular conduit, after the delivery subassembly is retracted;inflating the balloon dilation catheter to expand the support structures of the vascular conduit; anddeflating and removing the balloon delivery conduit before connecting the auxiliary device to the proximal end of the supply conduit.
  • 11. The method according to claim 9 further comprising: directing a balloon dilation catheter into the supply conduit after the delivery subassembly is retracted;inflating the balloon dilation catheter to expand the support structures of the supply conduit at the bifurcation joint; anddeflating and removing the balloon delivery catheter before connecting the auxiliary device to the proximal end of the supply conduit.
  • 12. The method according to claim 1 further comprising: capping a proximal end of the supply conduit after retracting the delivery subassembly.
  • 13. The method according to claim 12 further comprising: deairing the supply conduit before removing the cap and connecting the auxiliary device.
  • 14. The method according to claim 1, wherein the auxiliary device is a pump.
  • 15. A method of connecting a peripheral vessel to an auxiliary device with an anastomotic connector comprising a vascular conduit and a supply conduit, the vascular conduit having proximal and distal ends and is configured to reside within the peripheral vessel, the supply conduit having proximal and distal ends, wherein the distal end of the supply conduit forms a bifurcation joint with the vascular conduit and the proximal end of the supply conduit is configured to couple to the auxiliary device, the method comprising: coupling the anastomotic connector to a delivery subassembly, the delivery subassembly comprising a multi-lumen hub, a multi-lumen delivery shaft extending distally form the multi-lumen hub, and a secondary delivery shaft extending distally from the multi-lumen hub, wherein a distal portion of the secondary delivery shaft is received by a first lumen of the multi-lumen delivery shaft, the coupling including: directing the multi-lumen delivery shaft from the proximal end of the supply conduit, through the lumen of the supply conduit, through the lumen of the distal end of the vascular conduit, and distally from the distal end of the vascular conduit;directing the secondary delivery shaft into the distal end of the vascular conduit, through the lumen of the vascular conduit, and distally from the distal end of the vascular conduit, wherein a distal portion of the secondary delivery shaft is received by a first lumen of the multi-lumen delivery shaft;wrapping the proximal end of the vascular conduit around the supply conduit; andbackloading the coupled anastomotic connector with the delivery subassembly into a delivery sheath;directing the delivery sheath with the coupled anastomotic connector and delivery subassembly into the peripheral vessel;retracting the delivery sheath to thereby deploy the proximal and distal ends of the vascular conduit within the peripheral vessel;continuing the retracting to deploy the supply conduit;retracting the delivery sheath and the delivery subassembly from the anastomotic connector;deairing the supply conduit; andconnecting the auxiliary device to the proximal end of the supply conduit.
CROSS-REFERENCE TO RELATED APPLICATION

This application is a divisional of U.S. patent application Ser. No. 14/713,380, filed May 15, 2015, now patent Ser. No. 10/136,893, issued Nov. 27, 2018, which application is a divisional of U.S. patent application Ser. No. 12/829,425, filed Jul. 2, 2010, now U.S. Pat. No. 9,050,419, issued Jun. 9, 2015, which claims priority to U.S. Provisional Application Ser. No. 61/242,153, filed Sep. 14, 2009 the entirety of all of which are incorporated herein by reference.

US Referenced Citations (140)
Number Name Date Kind
3496939 Odiaga et al. Feb 1970 A
3683926 Suzuki Aug 1972 A
4142528 Whelan et al. Mar 1979 A
4230119 Blum Oct 1980 A
4503568 Madras Mar 1985 A
4512761 Raible Apr 1985 A
4712551 Rayhanabad Dec 1987 A
4822341 Colone Apr 1989 A
5041101 Seder et al. Aug 1991 A
5054484 Hebeler, Jr. Oct 1991 A
5254097 Schock Oct 1993 A
5425765 Tiefenbrun et al. Jun 1995 A
5443497 Venbrux Aug 1995 A
5449342 Hirose et al. Sep 1995 A
5456712 Maginot Oct 1995 A
5474540 Miller Dec 1995 A
5486159 Mahurkar Jan 1996 A
5522880 Barone et al. Jun 1996 A
5613980 Chauhan Mar 1997 A
5628783 Quiachon et al. May 1997 A
5669924 Shaknovich Sep 1997 A
5676670 Kim Oct 1997 A
5676696 Mardcade Oct 1997 A
5676697 McDonald Oct 1997 A
5693087 Parodi Dec 1997 A
5693088 Lazarus Dec 1997 A
5720735 Dorros Feb 1998 A
5755773 Evans et al. May 1998 A
5755778 Kleshinski May 1998 A
5807311 Palestrant Sep 1998 A
5807356 Finch et al. Sep 1998 A
5824036 Lauterjung Oct 1998 A
5921971 Agro et al. Jul 1999 A
6017363 Hojeibane Jan 2000 A
6019788 Butters Feb 2000 A
6030395 Nash et al. Feb 2000 A
6042569 Finch, Jr. Mar 2000 A
6053901 Finch, Jr. Apr 2000 A
6099497 Adams Aug 2000 A
6129738 Lashinski Oct 2000 A
6162196 Hart Dec 2000 A
6183509 Dibie Feb 2001 B1
6210430 Solem Apr 2001 B1
6210435 Piplani et al. Apr 2001 B1
6293955 Houser et al. Sep 2001 B1
6293965 Berg et al. Sep 2001 B1
6319278 Quinn Nov 2001 B1
6361544 Wilson Mar 2002 B1
6428567 Wilson et al. Aug 2002 B2
6451033 Berg et al. Sep 2002 B1
6468300 Freidberg Oct 2002 B1
6475232 Babbs et al. Nov 2002 B1
6475234 Richter et al. Nov 2002 B1
6482211 Choi Nov 2002 B1
6494889 Fleischman et al. Dec 2002 B1
6506202 Dutta et al. Jan 2003 B1
6508836 Wilson et al. Jan 2003 B2
6517558 Gittings et al. Feb 2003 B2
6524334 Thompson Feb 2003 B1
6558414 Layne May 2003 B2
6579312 Wilson et al. Jun 2003 B2
6579314 Lombardi et al. Jun 2003 B1
6585756 Strecker Jul 2003 B1
6592544 Mooney Jul 2003 B1
6645242 Quinn Nov 2003 B1
6652544 Houser et al. Nov 2003 B2
6669708 Nissenbaum et al. Dec 2003 B1
6719749 Schweikert Apr 2004 B1
6733522 Schmitt et al. May 2004 B2
6736838 Richter May 2004 B1
6740101 Houser et al. May 2004 B2
6740115 Lombardi et al. May 2004 B2
6770087 Layne et al. Aug 2004 B2
6786920 Shannon et al. Sep 2004 B2
6790225 Shannon et al. Sep 2004 B1
6808533 Goodwin et al. Oct 2004 B1
6843795 Houser et al. Jan 2005 B1
6860899 Rivelli, Jr. Mar 2005 B1
6866805 Hong et al. Mar 2005 B2
6875229 Wilson et al. Apr 2005 B2
6887265 Richter et al. May 2005 B2
6896699 Wilson et al. May 2005 B2
6899730 Rivelli, Jr. May 2005 B1
6911040 Johnson et al. Jun 2005 B2
6955688 Wilson et al. Oct 2005 B2
6969395 Eskuri Nov 2005 B2
6979338 Loshakove et al. Dec 2005 B1
6984243 Dwyer et al. Jan 2006 B2
6989071 Kocur et al. Jan 2006 B2
6994713 Berg et al. Feb 2006 B2
7014628 Bousquet Mar 2006 B2
7022131 Derowe et al. Apr 2006 B1
7063711 Loshakove et al. Jun 2006 B1
7083640 Lombardi et al. Aug 2006 B2
7094248 Bachinski et al. Aug 2006 B2
7108717 Freidberg Sep 2006 B2
7141060 Metz Nov 2006 B1
7285235 Rapacki Oct 2007 B2
7699864 Kick et al. Apr 2010 B2
7713193 Nance et al. May 2010 B2
7722568 Lenker et al. May 2010 B2
7780692 Nance et al. Aug 2010 B2
8500620 Lu Aug 2013 B2
20010003149 Utterberg et al. Jun 2001 A1
20010041902 Lepulu et al. Nov 2001 A1
20020019665 Dehdashtian et al. Feb 2002 A1
20020052648 McGuckin et al. May 2002 A1
20020099394 Houser Jul 2002 A1
20020169495 Gifford et al. Nov 2002 A1
20030195535 Swanson et al. Oct 2003 A1
20040153112 Nissenbaum et al. Aug 2004 A1
20040153143 Quachon et al. Aug 2004 A1
20040167478 Mooney Aug 2004 A1
20040168691 Sharkawy Sep 2004 A1
20040243095 Nimkar Dec 2004 A1
20050070933 Leiboff Mar 2005 A1
20050096585 Schon May 2005 A1
20050124937 Kick et al. Jun 2005 A1
20050165428 Franco Jul 2005 A1
20050251187 Beane Nov 2005 A1
20060052750 Lenker et al. Mar 2006 A1
20060135962 Kick et al. Jun 2006 A1
20060135963 Kick et al. Jun 2006 A1
20060135981 Lenker et al. Jun 2006 A1
20060200189 Nance et al. Sep 2006 A1
20060253102 Nance et al. Nov 2006 A1
20070179591 Baker et al. Aug 2007 A1
20070203572 Heuser et al. Aug 2007 A1
20080109058 Greenberg et al. May 2008 A1
20080172118 Johnson et al. Jul 2008 A1
20080195125 Hoffman Aug 2008 A1
20080200943 Barker et al. Aug 2008 A1
20080215008 Nance et al. Sep 2008 A1
20080243081 Nance et al. Oct 2008 A1
20090093873 Navia Apr 2009 A1
20090182188 Marseille et al. Jul 2009 A1
20090287182 Bishop et al. Nov 2009 A1
20090287183 Bishop et al. Nov 2009 A1
20100145267 Bishop et al. Jun 2010 A1
20100228077 Lenker et al. Sep 2010 A1
Foreign Referenced Citations (22)
Number Date Country
10033720 Jan 2002 DE
0838486 Feb 1996 JP
9511409 Nov 1997 JP
2002301083 Oct 2002 JP
2002534208 Oct 2002 JP
2003019137 Jan 2003 JP
2003250819 Sep 2003 JP
2003290233 Oct 2003 JP
2005517502 Jun 2005 JP
2008511419 Apr 2008 JP
2008513155 May 2008 JP
2009525128 Jul 2009 JP
9514442 Jun 1995 WO
0041633 Jul 2000 WO
0049951 Aug 2000 WO
2004043519 May 2004 WO
2006028925 Mar 2006 WO
2007089500 Aug 2007 WO
2008027869 Mar 2008 WO
2008027869 Mar 2008 WO
2009082718 Jul 2009 WO
2009082718 Jul 2009 WO
Non-Patent Literature Citations (13)
Entry
Japanese Patent Office, Notice of Reasons for Rejection in JP Application No. 2012-528794, dated Feb. 24, 2014.
Japanese Patent Office, Notice of Reasons for Rejection in JP Application No. 2014-206184, dated Aug. 31, 2015.
Japanese Patent Office, Decision of Rejection in JP Application No. 2014-206184, dated May 9, 2016.
U.S. Patent and Trademark Office, International Preliminary Report on Patentability in related International Application No. PCT/US10/048082, dated Dec. 6, 2011, 4 pages.
U.S. Patent and Trademark Office, International Preliminary Report on Patentability in related International Application No. PCT/US10/039782, dated Mar. 2, 2012, 9 pages.
Canadian Intellectual Property Office, Office Action in Canadian Application No. 2,768,567, dated Jan. 26, 2016.
European Patent Office, Supplementary Partial European Search Report in EP Application No. 10815780, dated Aug. 26, 2014.
Atrium Medical Corp., “Atrium iCAST Covered Stent Brochure,” at http://www.atriummed.com/EN/interventional/Dcouments/iCAST%20Brochure$2003603G.pdf (last visited Oct. 13, 2010).
Boston Scientific Corp., “Boston Scientific Announces CE Mark for SYMBIOT covered stent system: Symbiot II clinical trial results reported at PCR,” at http://www.ptca.org/press_rel/20020528pr_boston.html (last visited Oct. 13, 2010).
Cook Medical, “Aortic Intervention,” at http://www.cookmedical.com/ai/home.do (last visited Oct. 13, 2010).
Atrium Medical Corp., “FLIXENE IFG: The Best Engineered Dialysis Access Graft . . . There Can Only Be One,” at http://wwww.atriummed.com/en/vascular/Documents/FlixeneIFG%202-sidedflyer.pdf (last visited Dec. 3, 2010).
U.S. Patent and Trademark Office, International Search Report and Written Opinion in PCT Application No. PCT/US10/048082, dated Oct. 25, 2010.
U.S. Patent and Trademark Office, International Search Report and Written Opinion in PCT Application No. PCT/US10/39782, dated Aug. 10, 2010.
Related Publications (1)
Number Date Country
20190069898 A1 Mar 2019 US
Provisional Applications (1)
Number Date Country
61242153 Sep 2009 US
Divisions (2)
Number Date Country
Parent 14713380 May 2015 US
Child 16178729 US
Parent 12829425 Jul 2010 US
Child 14713380 US